(Q38056526)

27 August 2017

title

Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article (English)

1 reference

27 August 2017

1 reference

1 reference

1 reference

2

Morten Vatn

1 reference

27 August 2017

Peter Rolny

1

1 reference

27 August 2017

publication date

30 October 2012

1 reference

Scandinavian Journal of Gastroenterology

27 August 2017

published in

1 reference

27 August 2017

volume

48

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

131-135

1 reference

Predicting outcome in severe ulcerative colitis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Intensive intravenous regimen for severe attacks of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Further experience in the treatment of severe attacks of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

A review of infliximab use in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Acute severe colitis: infliximab and/or cyclosporine?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Cyclosporin for inflammatory bowel disease: mechanisms and possible actions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Review article: how and when to use ciclosporin in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Does anti-TNF therapy reduce the requirement for surgery in ulcerative colitis? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Longer term outcome of steroid refractory ulcerative colitis treated with intravenous cyclosporine without subsequent oral cyclosporine maintenance therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Ciclosporin use in acute ulcerative colitis: a long-term experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Conventional medical management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Therapeutic strategies for the management of ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

An evidence-based systematic review on medical therapies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Azathioprine without oral ciclosporin in the long-term maintenance of remission induced by intravenous ciclosporin in severe, steroid-refractory ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Treatment of ulcerative colitis refractory to steroid therapy by oral microemulsion cyclosporine (Neoral).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Is keeping the colon the ultimate marker of success in ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Colectomy rate in acute severe ulcerative colitis in the infliximab era.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Postoperative complications and mortality following colectomy for ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Treatment of choice for acute severe steroid-refractory ulcerative colitis is colectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Review article: colon-saving medical therapy vs. colectomy in ulcerative colitis - the case for colectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Antagonist: Early surgical intervention in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Surgery, inflammatory bowel disease and biological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Management of acute severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2012.733954

10.3109/00365521.2012.733954

21 January 2018

Identifiers

DOI

1 reference

release_iciz25lvcnczrglzpzbivzw3mm

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iciz25lvcnczrglzpzbivzw3mm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference